FLUPHENAZINE HYDROCHLORIDE

N/A

Manufactured by Rising Pharma Holdings, Inc.

426 FDA adverse event reports analyzed

Last updated: 2026-04-15

About FLUPHENAZINE HYDROCHLORIDE

FLUPHENAZINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rising Pharma Holdings, Inc.. The most commonly reported adverse reactions for FLUPHENAZINE HYDROCHLORIDE include SEDATION, DRUG INEFFECTIVE, ANXIETY, SUICIDE ATTEMPT, SCHIZOPHRENIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FLUPHENAZINE HYDROCHLORIDE.

Top Adverse Reactions

SEDATION19 reports
DRUG INEFFECTIVE15 reports
ANXIETY13 reports
SUICIDE ATTEMPT12 reports
SCHIZOPHRENIA11 reports
BLOOD PRESSURE DECREASED10 reports
BLOOD PRESSURE INCREASED10 reports
CHEST PAIN10 reports
PARKINSONISM10 reports
DYSPNOEA9 reports
NIGHTMARE9 reports
OEDEMA PERIPHERAL9 reports
THINKING ABNORMAL9 reports
ADVERSE DRUG REACTION8 reports
AKATHISIA8 reports
SELF INJURIOUS IDEATION8 reports
SUICIDAL IDEATION8 reports
ANOSOGNOSIA7 reports
DYSKINESIA7 reports
DYSTONIA7 reports
HYPERCHOLESTEROLAEMIA7 reports
SOMNOLENCE7 reports
HYPOTENSION6 reports
ORTHOSTATIC HYPERTENSION6 reports
WEIGHT INCREASED6 reports
DEPRESSION5 reports
DRUG INTERACTION5 reports
INTENTIONAL OVERDOSE5 reports
PNEUMONIA5 reports
THERAPEUTIC PRODUCT EFFECT DECREASED5 reports
ACUTE KIDNEY INJURY4 reports
ADVERSE EVENT4 reports
ANGER4 reports
HYPERGLYCAEMIA4 reports
LOSS OF CONSCIOUSNESS4 reports
OFF LABEL USE4 reports
PRODUCT DOSE OMISSION ISSUE4 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE4 reports
COAGULOPATHY3 reports
COMA3 reports
DELUSION3 reports
DIZZINESS3 reports
FALL3 reports
FATIGUE3 reports
GAIT DISTURBANCE3 reports
HOSPITALISATION3 reports
HYPOAESTHESIA3 reports
HYPOGLYCAEMIA3 reports
HYPONATRAEMIA3 reports
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION3 reports
MANIA3 reports
NAUSEA3 reports
OVERDOSE3 reports
PAIN3 reports
PANCREATITIS HAEMORRHAGIC3 reports
PSYCHOTIC DISORDER3 reports
TRANSIENT ISCHAEMIC ATTACK3 reports
URINARY TRACT INFECTION3 reports
ABDOMINAL PAIN2 reports
ABDOMINAL PAIN UPPER2 reports
ACCIDENTAL EXPOSURE TO PRODUCT2 reports
ACCIDENTAL OVERDOSE2 reports
AGITATION2 reports
AMNESIA2 reports
BRADYPNOEA2 reports
BRAIN OEDEMA2 reports
CARDIAC ARREST2 reports
CONTRAINDICATED PRODUCT PRESCRIBED2 reports
CONTUSION2 reports
COVID 192 reports
DEATH2 reports
DEMENTIA2 reports
DEVICE BREAKAGE2 reports
DEVICE DIFFICULT TO USE2 reports
DISORIENTATION2 reports
EXTRAPYRAMIDAL DISORDER2 reports
FEELING ABNORMAL2 reports
HAEMODYNAMIC INSTABILITY2 reports
HEADACHE2 reports
HYPERPROLACTINAEMIA2 reports
ILLNESS2 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION2 reports
ISCHAEMIC HEPATITIS2 reports
KETONURIA2 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME2 reports
NECK PAIN2 reports
NEUROLEPTIC MALIGNANT SYNDROME2 reports
PAPILLOEDEMA2 reports
PRODUCT USE IN UNAPPROVED INDICATION2 reports
PYREXIA2 reports
RENAL DISORDER2 reports
RHABDOMYOLYSIS2 reports
TOXICITY TO VARIOUS AGENTS2 reports
VOMITING2 reports
ABDOMINAL DISTENSION1 reports
ABNORMAL BEHAVIOUR1 reports
AGRANULOCYTOSIS1 reports
AMYLASE INCREASED1 reports
ANAL INCONTINENCE1 reports
ANORGASMIA1 reports

Report Outcomes

Out of 108 classified reports for FLUPHENAZINE HYDROCHLORIDE:

Serious 80.6%Non-Serious 19.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male50 (50.0%)
Female50 (50.0%)

Reports by Age

Age 558 reports
Age 447 reports
Age 335 reports
Age 615 reports
Age 303 reports
Age 323 reports
Age 413 reports
Age 453 reports
Age 132 reports
Age 172 reports
Age 252 reports
Age 422 reports
Age 482 reports
Age 522 reports
Age 632 reports
Age 872 reports
Age 161 reports
Age 211 reports
Age 241 reports
Age 261 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with FLUPHENAZINE HYDROCHLORIDE?

This profile reflects 426 FDA FAERS reports that mention FLUPHENAZINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for FLUPHENAZINE HYDROCHLORIDE?

Frequently reported terms in FAERS include SEDATION, DRUG INEFFECTIVE, ANXIETY, SUICIDE ATTEMPT, SCHIZOPHRENIA, BLOOD PRESSURE DECREASED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures FLUPHENAZINE HYDROCHLORIDE?

Labeling and FAERS entries often list Rising Pharma Holdings, Inc. in connection with FLUPHENAZINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.